1nhaler, a Scotland-based drug delivery device developer, has secured £2.2 million in follow-on funding to progress its novel pop-up cardboard inhaler towards first regulatory approval.

The fund builds on a 2024 round which unlocked more than £5.3m of investment.

Scottish Enterprise backing has strengthened the long-term competitiveness of nationally important manufacturing site INEOS O&P UK, the company’s olefins and polymers chemical production site at Grangemouth